Huilin Ou

Ningbo, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Enhanced Programmed Cell Death Protein 1/Programmed Cell Death Ligand 1 Expression Induced by Severe Influenza A Virus Infection Impairs Host's Antiviral Response.

Enhanced Programmed Cell Death Protein 1/Programmed Cell Death Ligand 1 Expression Induced by Severe Influenza A Virus Infection Impairs Host's Antiviral Response.

Journal: Viral immunology

Published: September 12, 2022

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection.

Bioinformatic analysis of PD-1 checkpoint blockade response in influenza infection.

Journal: BMC genomic data

Published: November 13, 2021

MicroRNA Expression Profiling of Lung Cancer with Differential Expression of the RON Receptor Tyrosine Kinase.

MicroRNA Expression Profiling of Lung Cancer with Differential Expression of the RON Receptor Tyrosine Kinase.

Journal: Journal of oncology

Published: June 16, 2021

miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.

miR-21-5p promotes lung adenocarcinoma cell proliferation, migration and invasion via targeting WWC2.

Journal: Cancer biomarkers : section A of Disease markers

Published: July 06, 2020

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

Open-label phase I clinical trial of Ad5-EBOV in Africans in China.

Journal: Human vaccines & immunotherapeutics

Published: July 15, 2017

Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB/c mice.

Longevity of protective immune responses induced by a split influenza A (H7N9) vaccine mixed with MF59 adjuvant in BALB/c mice.

Journal: Oncotarget

Published: May 26, 2017

High-throughput sequencing identifies HIV-1-replication- and latency-related miRNAs in CD4+ T cell lines.

High-throughput sequencing identifies HIV-1-replication- and latency-related miRNAs in CD4+ T cell lines.

Journal: Archives of virology

Published: November 17, 2016

Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine.

Preclinical evaluation of the safety and pathogenicity of a live attenuated recombinant influenza A/H7N9 seed strain and corresponding MF59-adjuvanted split vaccine.

Journal: Oncotarget

Published: July 07, 2016

Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice.

Analysis of the immunogenicity and bioactivities of a split influenza A/H7N9 vaccine mixed with MF59 adjuvant in BALB/c mice.

Journal: Vaccine

Published: January 05, 2016

Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study.

Efficacy of oseltamivir-peramivir combination therapy compared to oseltamivir monotherapy for Influenza A (H7N9) infection: a retrospective study.

Journal: BMC infectious diseases

Published: July 16, 2015

Surgical treatment for the proliferative retinal detachment associated with macular hole in the morning glory syndrome.

Surgical treatment for the proliferative retinal detachment associated with macular hole in the morning glory syndrome.

Journal: Eye science

Published: January 11, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026